Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

DANAHER CORPORATION

(DHR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

DANAHER CORP /DE/ : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

01/13/2021 | 07:25am EDT

ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION



On January 13, 2021, in advance of a public webcast presentation at the J.P.
Morgan Healthcare Conference on the same date, Danaher Corporation issued a
press release regarding the Company's anticipated financial performance for the
fourth quarter of 2020 and furnished pursuant to Item 2.02 of Form 8-K such
press release as well as the presentation slides attached hereto, each of which
is incorporated by reference herein. The presentation slides attached hereto
contain certain information regarding Danaher's anticipated financial
performance for 2020.
This information shall not be deemed "filed" for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), or
incorporated by reference in any filing under the Securities Act of 1933, as
amended, or the Exchange Act, except as shall be expressly set forth by specific
reference in such a filing.


ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

              (c) Exhibits:

   Exhibit No.                         Description

      99.1                               Press release - "Danaher CEO to

Comment on Financial Performance"

     99.1PRE                             Selected Danaher Presentation 

Slides for J.P. Morgan Healthcare

                                       Conference on January 13, 2021
       104                             Cover Page Interactive Data File 

(formatted as inline XBRL with applicable

                                       taxonomy extension information contained in Exhibits 101)



--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

All news about DANAHER CORPORATION
04:16pDANAHER : Schedules Third Quarter 2021 Earnings Conference Call
PR
09/15DANAHER CORP /DE/ : Change in Directors or Principal Officers, Financial Statements and Ex..
AQ
09/14DANAHER : Keeps Quarterly Cash Dividend Unchanged at $0.21 a Share, Payable Oct. 29 to Sha..
MT
09/14DANAHER : Announces Quarterly Dividends
PR
09/14Danaher Corporation Approves Regular Quarterly Cash Dividend, Payable on October 29, 20..
CI
09/10DANAHER : Credit Suisse Raises Danaher's PT to $370 from $306, Notes Heightened Conviction..
MT
09/08DANAHER : RBC Raises Price Target on Danaher to $332 From $304 Ahead of Analyst Day, Maint..
MT
09/03DANAHER : Helping Customers Make Better Beer -- and Improve Sustainability
PU
09/01SCIEX : Presents Industry First Multi-Capillary System for CE-SDS, the BioPhase 8800 Syste..
BU
09/01SCIEX : Builds on Cadence of Innovation in Biopharma With Biologics Explorer
BU
More news
Analyst Recommendations on DANAHER CORPORATION
More recommendations